Journal article
Crucial role for the VWF A1 domain in binding to type IV collagen
Blood, v 125(14), pp 2297-2304
02 Apr 2015
PMID: 25662333
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Von Willebrand factor (VWF) contains binding sites for platelets and for vascular collagens to facilitate clot formation at sites of injury. Although previous work has shown that VWF can bind type IV collagen (collagen 4), little characterization of this interaction has been performed. We examined the binding of VWF to collagen 4 in vitro and extended this characterization to a murine model of defective VWF-collagen 4 interactions. The interactions of VWF and collagen 4 were further studied using plasma samples from a large study of both healthy controls and subjects with different types of von Willebrand disease (VWD). Our results show that collagen 4 appears to bind VWF exclusively via the VWF A1 domain, and that specific sequence variations identified through VWF patient samples and through site-directed mutagenesis in the VWF A1 domain can decrease or abrogate this interaction. In addition, VWF-dependent platelet binding to collagen 4 under flow conditions requires an intact VWF A1 domain. We observed that decreased binding to collagen 4 was associated with select VWF A1 domain sequence variations in type 1 and type 2M VWD. This suggests an additional mechanism through which VWF variants may alter hemostasis.
Metrics
Details
- Title
- Crucial role for the VWF A1 domain in binding to type IV collagen
- Creators
- Veronica H Flood - Children's Hospital of WisconsinAbraham C Schlauderaff - Children's Hospital of WisconsinSandra L Haberichter - Children's Hospital of WisconsinTricia L SlobodianukPaula M JacobiDaniel B BellissimoPamela A ChristophersonKenneth D FriedmanJoan Cox Gill - Children's Hospital of WisconsinRaymond G Hoffmann - Medical College of WisconsinRobert R Montgomery - Children's Hospital of WisconsinZimmerman Program InvestigatorsAaron Dunn - Radiology (Radiologic Sciences)
- Publication Details
- Blood, v 125(14), pp 2297-2304
- Publisher
- American Society of Hematology (ASH)
- Grant note
- R01 HL033721 / NHLBI NIH HHS HL081588 / NHLBI NIH HHS K08HL102260 / NHLBI NIH HHS K08 HL102260 / NHLBI NIH HHS P01 HL044612 / NHLBI NIH HHS T35 HL072483 / NHLBI NIH HHS P01 HL081588 / NHLBI NIH HHS HL33721 / NHLBI NIH HHS HL044612 / NHLBI NIH HHS
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiology (Radiologic Sciences)
- Web of Science ID
- WOS:000354626900017
- Scopus ID
- 2-s2.0-84926664083
- Other Identifier
- 991019173460604721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Hematology